霸王茶姬美股大跌，此前因“咖啡因”登上热搜

Core Viewpoint - The stock of BaWang Tea Ji fell over 14% on December 26, reaching a record low since its IPO, amid concerns over high caffeine content in its products, which has led to discussions on social media [1] Group 1: Caffeine Content Concerns - BaWang Tea Ji's products have been reported to contain caffeine levels as high as 220mg per cup, causing adverse reactions such as palpitations and insomnia among consumers [1] - In response to the caffeine controversy, BaWang Tea Ji stated that the caffeine content in their brewed tea is comparable to that of a latte and significantly lower than that of an Americano, based on existing public data and testing results [1][4] Group 2: Product Innovation and Development - The company has been actively exploring tea processing techniques and has collaborated with experts to develop new products, such as "Light Caffeine · Bo Ya Jue Xuan," which reduces caffeine content by approximately 50% while maintaining the core flavor of the tea [2][6] - BaWang Tea Ji emphasizes the use of whole leaf tea rather than tea fragments or industrial flavoring agents, which contributes to a richer taste and a more natural caffeine presence [5][6] Group 3: Future Directions and Cultural Significance - The company aims to continue its exploration of tea's composition and balance, with plans to develop caffeine-free tea options to cater to consumers sensitive to caffeine [6] - BaWang Tea Ji recognizes the importance of cultural confidence and the need for sustained product development and innovation to promote Chinese tea globally, drawing parallels with the historical journey of coffee [7][8]